Change Share Class

LuxTopic - Aktien Europa B

LuxTopic - Aktien Europa B Header Image
Minimum investment: 1,000,000 EUR
As at:
1268.37 EUR
1268.37 EUR
The investment focus of LuxTopic - Aktien Europa is on shares of major European companies. These organisations generate their revenues not only in Europe but also in the high-growth regions of the world. They have sound assets and high earning power. A technical selection process is used to choose individual stocks from the universe of European blue chips. The active risk management is also used to limit the negative effect of market downturns. In addition to equities, it can also invest in fixed and variable-rate securities.

Legal Information / Disclaimer:

The collective investment scheme ("the Fund"), is a fund on a contractual basis under the law of Luxembourg. Regarding the publication of performance data of the Fund it should be noted that the historic performance does not represent an indicator for the current or future performance and the performance data do not take account of the commissions and costs incurred on the issue and redemption of units. First Independent Fund Services Ltd., Klausstrasse 33, CH-8008 Zurich acts as the Swiss Representative (the "Swiss Representative") and NPB Neue Privat Bank Ltd., Limmatquai 1, P.O. Box, CH-8022 Zurich acts as the Paying Agent in Switzerland ( the "Swiss Paying Agent") for the Fund. Copies of the prospectus (incl. management regulations), the Key Investor Information Document, as well as annual and semi-annual reports of the Fund may be obtained free of charge from the Swiss Representative in Zurich.

*) © 2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.